Common antigen for colorectal and mucinous ovarian tumors and pr

Details Common antigen for colorectal and mucinous ovarian tumors and pr Common antigen for colorectal and mucinous ovarian tumors and pr

1986-11-21

1990-10-09

Draper, Garnette D.

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

530395, 530387, 530389, 530827, 424 11, 424 858, 424 88, 424551, 424559, 436544, 436543, 436545, 436547, C07K 1500, A61K 3900

Patent

active

049621874

ABSTRACT:
A purified common antigen for colorectal and mucinous ovarian cancer (COTA) is provided which is antigenically distinct from CSAp, CEA and Ca 19-9. The COTA antigen is useful for producing a COTA antibody which is nonreactive with CSAp, CEA or Ca 19-9.

REFERENCES:
patent: 3697638 (1972-10-01), Hansen
patent: 4273537 (1981-10-01), Wong
patent: 4293537 (1981-10-01), Wong
patent: 4468457 (1984-08-01), Goldenberg et al.
patent: 4489167 (1984-12-01), Ochi et al.
Pant et al Tumor Biology 5(5) 1984, pp. 243-254.
Ma et al. Pathology 15(4) 1983, pp. 385 -391.
Pant et al Nucl Med Biol 100, 1987 pp. 1-9.
CA #24283r Thomson et al (vol. 93).
CA #83567x Jeny et al (vol. 100).
Pant, "Advances in Cancer Research", XI Annual Meeting, Stockholm, Sweden, Sep. 11-15, 1983, p. 25.
Thomson, Eur. J. Cancer, 16(4), 539-51 (Eng) 1980.

Affiliated with

Also associated with

Rating

Common antigen for colorectal and mucinous ovarian tumors and pr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Common antigen for colorectal and mucinous ovarian tumors and pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Common antigen for colorectal and mucinous ovarian tumors and pr will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-974349